Source: Ultromics Blog

Ultromics Blog How does Artificial Intelligence improve diagnosis for Cardiac Amyloidosis?

Early diagnosis of cardiac amyloidosis (CA) can prevent irreversible heart damage, guide appropriate disease management and improve quality of life and prognosis. The complexity of diagnostic techniques, however, can made CA detection extremely challenging.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Ross Upton's photo - Co-Founder & CEO of Ultromics

Co-Founder & CEO

Ross Upton

CEO Approval Rating

65/100

Read more